ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 2456

$901K Total Retail Price of All Prescriptions

Rank: 56 out of 2456

943 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 943 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 943 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 16,601 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 2,004 1,652 1 2
LISINOPRIL 1,344 987 2 1
OMEPRAZOLE 1,029 826 3 3
METFORMIN HCL 753 537 4 11
PRAVASTATIN SODIUM 731 568 5 15
LEVOTHYROXINE SODIUM 616 457 6 4
CRESTOR 613 417 7 25
METOPROLOL TARTRATE 524 453 8 10
ATORVASTATIN CALCIUM 476 366 9 12
FUROSEMIDE 470 406 10 8
LOSARTAN POTASSIUM 418 347 11 18
AMLODIPINE BESYLATE 391 342 12 5
HYDROCHLOROTHIAZIDE 368 300 13 7
CITALOPRAM HBR 338 247 14 14
METOPROLOL SUCCINATE 323 245 15 13
WARFARIN SODIUM 318 285 16 9
ENALAPRIL MALEATE 250 179 17 70
GLIPIZIDE 250 220 17 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 242 195 19 41
GABAPENTIN 239 187 20 16
POLYETHYLENE GLYCOL 3350 229 192 21 64
RANITIDINE HCL 219 170 22 31
PROAIR HFA 207 142 23 22
FLUTICASONE PROPIONATE 174 151 24 30
ATENOLOL 174 146 24 6
DIOVAN 169 141 26 26
PANTOPRAZOLE SODIUM 145 122 27 37
ACETAMINOPHEN-CODEINE 140 120 S3 28 106
SERTRALINE HCL 132 99 29 21
AZITHROMYCIN 130 100 30 60
PAROXETINE HCL 126 124 31 56
GLYBURIDE 123 102 R 32 40
AMITRIPTYLINE HCL 121 86 R 33 83
TRAMADOL HCL 120 108 34 24
INSULIN SYRINGE 118 71 35 72
ALENDRONATE SODIUM 117 115 36 19
ZOLPIDEM TARTRATE 115 86 37 28
JANUVIA 113 86 38 81
ZETIA 111 88 39 86
MECLIZINE HCL 101 98 40 107
CLONIDINE HCL 101 84 40 111
SYMBICORT 101 78 40 138
NIFEDIPINE ER 98 94 43 61
METHYLPREDNISOLONE 97 71 44 229
LOSARTAN-HYDROCHLOROTHIAZIDE 91 88 45 117
TRIAMTERENE-HCTZ 89 83 46 53
CLOPIDOGREL 88 79 47 55
DILTIAZEM 24HR ER 79 72 48 78
ADVAIR DISKUS 78 60 49 36
DOXAZOSIN MESYLATE 76 61 50 71
LABETALOL HCL 72 64 51 128
GLIPIZIDE ER 71 56 52 89
TRAZODONE HCL 70 54 53 17
HYDRALAZINE HCL 70 65 53 105
SINGULAIR 70 53 53 149
NIASPAN 69 39 56 181
BUMETANIDE 68 58 57 167
NAPROXEN 68 58 57 109
CIPROFLOXACIN HCL 68 57 57 87
NEXIUM 65 52 60 80
FLOVENT HFA 65 48 60 104
LORAZEPAM 64 57 62 67
NYSTATIN 64 58 62 99
GLIPIZIDE XL 63 56 64 168
ALPRAZOLAM 62 56 65 141
LIPITOR 61 47 66 63
TAMSULOSIN HCL 60 56 67 32
HUMALOG MIX 75-25 60 14 67 258
GLIMEPIRIDE 60 43 67 74
ALLOPURINOL 59 52 70 27
ISOSORBIDE MONONITRATE ER 59 51 70 48
CARVEDILOL 58 48 72 54
OXYCODONE-ACETAMINOPHEN 57 34 S2 73 35
FENOFIBRATE 55 37 74 68
TRICOR 55 23 74 163
LOVASTATIN 55 42 74 34
PREDNISONE 55 43 74 39
DIOVAN HCT 55 55 74 139
MONTELUKAST SODIUM 54 43 79 216
DONEPEZIL HCL 53 53 80 23
PEN NEEDLE 51 32 81 150
SPIRIVA 51 40 81 43
NOVOLOG MIX 70-30 50 39 83 278
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.